Zitate (Citations)
1 publicationsPublikationen von Forschern, die dieses Produkt verwendenBeschreibung (Description)
Isogarcinol is a polyprenylated benzophenone natural compound extracted from plants of the Garciniagenus. Isogarcinol is also an effective inhibitor of acetylcholinesterase (AChE; IC₅₀=1.13μM) and butyrylcholinesterase (BChE; IC₅₀=8.30μM)[1-2]. Isogarcinol exhibits not only antileishmanial activity but also anticancer and immunomodulatory activities[3-4].
In vitro, breast cancer cell lines MDA-MB-231, MCF-7, T47D, and BT-549 were treated with Isogarcinol (1-17μM). Isogarcinol significantly inhibited cell viability, proliferation, invasion, and migration, while promoting apoptosis[5]. Human promyelocytic leukemia cells (HL-60 cells) were treated with Isogarcinol (5–20μg/mL) for 24–48 hours. Isogarcinol significantly inhibited cell proliferation and induced apoptosis, accompanied by G2/M phase cell cycle arrest[6].
In vivo, BALB/c mice were orally administered Isogarcinol (40–100mg/kg) daily for 6 days. Isogarcinol significantly suppressed 2,4-dinitrofluorobenzene (DNFB)-induced delayed-type hypersensitivity (DTH), alleviated ear swelling, and reduced the thymic index[7]. Chronic graft-versus-host disease (cGVHD) model BDF1 mice were orally administered Isogarcinol (30–60mg/kg) daily for 10 weeks. Isogarcinol significantly reduced proteinuria levels, improved renal histopathological damage, and corrected abnormal serum levels of blood urea nitrogen, creatinine, triglycerides, and cholesterol[8].
References:
[1] Schobert R, Biersack B. Chemical and Biological Aspects of Garcinol and Isogarcinol: Recent Developments. Chem Biodivers. 2019 Sep;16(9):e1900366.
[2] Lenta BN, Vonthron-Sénécheau C, Weniger B, et al. Leishmanicidal and cholinesterase inhibiting activities of phenolic compounds from Allanblackia monticola and Symphonia globulifera. Molecules. 2007 Jul 20;12(8):1548-57.
[3] Chen S, Han K, Li H, et al. Isogarcinol Extracted from Garcinia mangostana L. Ameliorates Imiquimod-Induced Psoriasis-like Skin Lesions in Mice. J Agric Food Chem. 2017 Feb 1;65(4):846-857.
[4] Matsumoto K, Akao Y, Kobayashi E, et al. Cytotoxic benzophenone derivatives from Garcinia species display a strong apoptosis-inducing effect against human leukemia cell lines. Biol Pharm Bull. 2003 Apr;26(4):569-71.
[5] Zhang D, Chu Y, Li M, et al. Isogarcinol Reduces MARS Levels and Deactivates the PI3K/AKT Pathway to Suppress the Malignant Properties of Breast Cancer Cells. Cell Biochem Biophys. 2025 Sep;83(3):3437-3449.
[6] Pieme CA, Ambassa P, Yankep E, et al. Epigarcinol and isogarcinol isolated from the root of Garcinia ovalifolia induce apoptosis of human promyelocytic leukemia (HL-60 cells). BMC Res Notes. 2015 Nov 23;8:700.
[7] Cen J, Shi M, Yang Y, et al. Isogarcinol is a new immunosuppressant. PLoS One. 2013 Jun 13;8(6):e66503.
[8] Li W, Li H, Zhang M, et al. Isogarcinol Extracted from Garcinia mangostana L. Ameliorates Systemic Lupus Erythematosus-like Disease in a Murine Model. J Agric Food Chem. 2015 Sep 30;63(38):8452-9.
Protokoll (Protocol)
| Cell experiment [1]: | |
Cell lines | MDA-MB-231, MCF-7, T47D, and BT-549 cells (human breast cancer cell lines) |
Preparation Method | Breast cancer (BC) cells were cultured in DMEM supplemented with 10% FBS and 1% antibiotics at 37°C, 5% CO₂. BC cells were treated with Isogarcinol at concentrations of 1, 5, 9, 13, and 17μM for 48 hours for viability assessment. |
Reaction Conditions | 1-17µM; 48h |
Applications | Isogarcinol (13μM) significantly reduced the viability, proliferation, colony formation, invasion, and migration capacities of breast cancer cells, while promoting cell apoptosis. Isogarcinol treatment also decreased the protein level of methionyl-tRNA synthetase (MARS) and deactivated the PI3K/AKT signaling pathway in BC cells. |
| Animal experiment [2]: | |
Animal models | BDF1 (C57BL/6 × DBA/2) mice with chronic graft-versus-host disease (cGVHD) |
Preparation Method | Mice were injected intravenously with 6 × 10⁷ DBA/2 spleen cells at day -7 and day 0 to induce cGVHD. Isogarcinol (30–60mg/kg; dissolved in 20% DMSO + 80% distilled water) was administered daily by oral gavage from day 1 until the end of the experiment. |
Dosage form | 30-60mg/kg; oral gavage; daily for 10 weeks. |
Applications | Isogarcinol (60mg/kg) significantly reduced proteinuria, improved renal histopathology, and corrected abnormal serum levels of blood urea nitrogen, creatinine, triglyceride, and cholesterol. Isogarcinol also decreased serum anti-dsDNA antibody and IgG1 concentrations, suppressed CD4⁺ T cell activation (reduced CD4/CD8 ratio and Th1/Th2 cytokine expression), and lowered inflammatory cytokine levels (TNF-α, IL-6, IL-1β) in kidneys and macrophages. |
References: | |
Produktdokumente (Product Documents)
Chemische Eigenschaften (Chemical Properties)
Verwenden Sie Stammlösungen bei Lagerung bei -80°C innerhalb von 6 Monaten bzw. bei -20°C innerhalb von 1 Monat.
Zur Verbesserung der Löslichkeit das Röhrchen auf 37°C erwärmen und für eine angemessene Dauer beschallen.
Rechner (Calculators)Molarität / Verdünnung / Molekulargewicht / Einheitenumrechnung / In-vivo-Formulierung / Löslichkeit
Reviews
Review for Isogarcinol
- 5 Star100%
- 4 Star0%
- 3 Star0%
- 2 Star0%
- 1 Star0%
